ArticlemAbs
Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions.
Gregory L Moore et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
145 papers cite itlatest 60 shown
trialcites it